Back to Biochemistry : Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas - 02/02/23
Abstract |
There is increasing recognition of the high prevalence of hereditary predisposition syndromes in patients diagnosed with paraganglioma/pheochromocytoma. It is widely acknowledged that germline pathogenic alterations of the succinate dehydrogenase complex genes (SDHA, SDHB, SDHC, SDHD, SDHAF2) contribute to the pathogenesis of most of these tumors. Herein, we have provided an update on the biology and diagnosis of succinate dehydrogenase-deficient paraganglioma/pheochromocytoma, including the molecular biology of the succinate dehydrogenase complex, mechanisms and consequences of inactivation of this complex, the prevalence of pathogenic alterations, and patterns of inheritance.
Le texte complet de cet article est disponible en PDF.Keywords : Paraganglioma, Pheochromocytoma, Succinate dehydrogenase, SDHA, SDHB, SDHC, SDHD, SDHAF2
Plan
| Sources of Support: None. |
Vol 16 - N° 1
P. 119-129 - mars 2023 Retour au numéro
Article précédent
- On the Chopping Block : Overview of DICER1 Mutations in Endocrine and Neuroendocrine Neoplasms
- Carl Christofer Juhlin
- All Together Now : Standardization of Nomenclature for Neuroendocrine Neoplasms across Multiple Organs
- Pari Jafari, Aliya N. Husain, Namrata Setia
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?